Induced Pluripotent Stem Cells (iPSC)

Custom organoid cultures developed from individual patient tumor samples for personalized medicine applications, drug sensitivity testing, and treatment planning in oncology.

Specialized organoid systems designed for tissue regeneration research, including organ-specific models for studying developmental biology and therapeutic regeneration strategies.

A comprehensive organoid culture and development platform designed for creating three-dimensional tissue models from patient or donor cells. The system supports the establishment and maintenance of organoid biobanks for research and therapeutic applications.

A three-dimensional in vitro cell culture system that establishes patient-derived tumor organoid models highly similar to patient tumor characteristics. The tumor organoids maintain high consistency with patient tumor pathological, molecular, and genetic features while enabling personalized drug sensitivity assessment, with reported accuracy up to 80%.

A biobank repository containing renewable primary cancer cells sourced from patient samples. This resource provides authentic tumor cell models for drug testing, molecular profiling, and precision oncology research.

An integrated organoid-based system for preclinical drug screening and development, enabling pharmaceutical companies to test compound efficacy on relevant tissue models.

Laboratory models simulating cellular and organ conditions for research purposes in cell biology and tissue engineering studies.

HLA-typed primary cells from diverse donors for immunological drug development and clinical research. These GMP-optimized cell culture products enable preclinical testing of therapeutics with standardized human immune profiling to predict clinical efficacy and safety outcomes.

Cancer organoid growth kit utilizing organ-on-chip technology to create high-fidelity human tissue models for drug efficacy evaluation and clinical treatment planning. Enables personalized medicine through rapid assessment of therapeutic response and toxicity in cancer research and oncology applications.